Phase IV, randomized, evaluator-masked clinical trial, on the effectiveness of early introduction of levosimendan in patients with acute decompensation of moderate / severe chronic heart failure in the hospital emergency room [Ensayo clinico en fase IV, aleatorizado, enmascarado para el evaluador, de la eficacia de la introduccion precoz de levosimendan en pacientes con descompensacion aguda de insuficiencia cardiaca cronica moderada/severa en un servicio de urgencias hospitalarias]

Trial Profile

Phase IV, randomized, evaluator-masked clinical trial, on the effectiveness of early introduction of levosimendan in patients with acute decompensation of moderate / severe chronic heart failure in the hospital emergency room [Ensayo clinico en fase IV, aleatorizado, enmascarado para el evaluador, de la eficacia de la introduccion precoz de levosimendan en pacientes con descompensacion aguda de insuficiencia cardiaca cronica moderada/severa en un servicio de urgencias hospitalarias]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2011

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Decompensated heart failure; Dyspnoea
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top